Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154710 | SCV000204390 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Ile640Ile in Exon 15 of DSP: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence and has been identified in 0.5% (17/3738) of Afri can American chromosomes from a broad population by the NHLBI Exome Sequencing P roject (http://evs.gs.washington.edu/EVS; dbSNP rs74806300). |
Ambry Genetics | RCV000241912 | SCV000318428 | likely benign | Cardiovascular phenotype | 2016-05-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001719958 | SCV000518103 | likely benign | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000472938 | SCV000555764 | benign | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma; Arrhythmogenic right ventricular dysplasia 8 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154710 | SCV000919290 | benign | not specified | 2018-05-29 | criteria provided, single submitter | clinical testing | Variant summary: DSP c.1920C>T alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00054 in 275424 control chromosomes, predominantly at a frequency of 0.0057 within the African subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within African control individuals in the gnomAD database is approximately 228 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSP causing Cardiomyopathy phenotype (2.5e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African origin. To our knowledge, no occurrence of c.1920C>T in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Color Diagnostics, |
RCV001183978 | SCV001349840 | benign | Cardiomyopathy | 2018-11-25 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000154710 | SCV001433074 | likely benign | not specified | 2020-05-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003998266 | SCV004821460 | benign | Arrhythmogenic cardiomyopathy with wooly hair and keratoderma | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000154710 | SCV001739546 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000154710 | SCV001923571 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001719958 | SCV001973330 | likely benign | not provided | no assertion criteria provided | clinical testing |